Matt Helms
Private Equity Investor bij BioGenerator (Venture Capital)
Profiel
Matt Helms is currently the Managing Director at BioGenerator (Venture Capital).
Previously, he held the position of Vice President at NewLeaf Symbiotics, Inc. from 2019 to 2020, and at Bayer Crop Science Solutions LLC from 2018 to 2019.
Mr. Helms obtained an MBA from Washington University in St. Louis in 2008 and an undergraduate degree from the University of Illinois in 1996.
Actieve functies van Matt Helms
Bedrijven | Functie | Begin |
---|---|---|
BioGenerator (Venture Capital)
BioGenerator (Venture Capital) Investment ManagersFinance BioGenerator (Venture Capital) (BioGenerator) is a venture capital subsidiary of BioGenerator founded in 2003. The firm is headquartered in St. Louis, Missouri. | Private Equity Investor | 01-09-2022 |
Eerdere bekende functies van Matt Helms
Bedrijven | Functie | Einde |
---|---|---|
NewLeaf Symbiotics, Inc.
NewLeaf Symbiotics, Inc. Chemicals: AgriculturalProcess Industries NewLeaf Symbiotics, Inc. develops and commercializes a family of beneficial bacteria. It commercializes Pink Pigmented Facultative Methylotrophs bacteria that improves plant health, promote early growth, and increase crop yield. The company was founded by Stephen Kahn, Thomas R. Laurita and Michael Bielski in 2012 and is headquartered in St. Louis, MO. | Private Equity Investor | 31-01-2020 |
Bayer Crop Science Solutions LLC | Private Equity Investor | 02-02-2019 |
Opleiding van Matt Helms
Washington University in St. Louis | Masters Business Admin |
University of Illinois | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
BioGenerator (Venture Capital)
BioGenerator (Venture Capital) Investment ManagersFinance BioGenerator (Venture Capital) (BioGenerator) is a venture capital subsidiary of BioGenerator founded in 2003. The firm is headquartered in St. Louis, Missouri. | Finance |
NewLeaf Symbiotics, Inc.
NewLeaf Symbiotics, Inc. Chemicals: AgriculturalProcess Industries NewLeaf Symbiotics, Inc. develops and commercializes a family of beneficial bacteria. It commercializes Pink Pigmented Facultative Methylotrophs bacteria that improves plant health, promote early growth, and increase crop yield. The company was founded by Stephen Kahn, Thomas R. Laurita and Michael Bielski in 2012 and is headquartered in St. Louis, MO. | Process Industries |
Bayer Crop Science Solutions LLC |